Assessing Refill Data Among Different Classes of Antidepressants

Overview

Journal Fed Pract

Specialty Health Services

Date 2019 Nov 28

PMID 31772497

Authors

Hayden Stewart

Saadia Basit

Affiliations

Soon will be listed here.

Abstract

No significant difference was seen in between-class adherence when comparing SSRIs, SNRIs, bupropion, and mirtazapine during a 3-month study of veterans newly initiated on antidepressants.

References

Manzano-Garcia M, Perez-Guerrero C, Alvarez de Sotomayor Paz M, Robustillo-Cortes M, Almeida-Gonzalez C, Morillo-Verdugo R . Identification of the Medication Regimen Complexity Index as an Associated Factor of Nonadherence to Antiretroviral Treatment in HIV Positive Patients. Ann Pharmacother. 2018; 52(9):862-867. DOI: 10.1177/1060028018766908. View

Fortney J, Pyne J, Edlund M, Stecker T, Mittal D, Robinson D . Reasons for antidepressant nonadherence among veterans treated in primary care clinics. J Clin Psychiatry. 2011; 72(6):827-34. DOI: 10.4088/JCP.09m05528blu. View

Watkins K, Paddock S, Zhang L, Wells K . Improving care for depression in patients with comorbid substance misuse. Am J Psychiatry. 2006; 163(1):125-32. DOI: 10.1176/appi.ajp.163.1.125. View

Sansone R, Sansone L . Antidepressant adherence: are patients taking their medications?. Innov Clin Neurosci. 2012; 9(5-6):41-6. PMC: 3398686. View

Libby A, Fish D, Hosokawa P, Linnebur S, Metz K, Nair K . Patient-level medication regimen complexity across populations with chronic disease. Clin Ther. 2013; 35(4):385-398.e1. DOI: 10.1016/j.clinthera.2013.02.019. View

Ho S, Jacob S, Tangiisuran B . Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study. PLoS One. 2017; 12(6):e0179290. PMC: 5470687. DOI: 10.1371/journal.pone.0179290. View

Gaspar F, Zaidel C, Dewa C . Rates and Determinants of Use of Pharmacotherapy and Psychotherapy by Patients With Major Depressive Disorder. Psychiatr Serv. 2019; 70(4):262-270. DOI: 10.1176/appi.ps.201800275. View

Santarsieri D, Schwartz T . Antidepressant efficacy and side-effect burden: a quick guide for clinicians. Drugs Context. 2015; 4:212290. PMC: 4630974. DOI: 10.7573/dic.212290. View

Magura S, Rosenblum A, Villano C, Vogel H, Fong C, Betzler T . Dual-focus mutual aid for co-occurring disorders: a quasi-experimental outcome evaluation study. Am J Drug Alcohol Abuse. 2007; 34(1):61-74. PMC: 3525112. DOI: 10.1080/00952990701764623. View

10.

Magura S, Rosenblum A, Fong C . Factors associated with medication adherence among psychiatric outpatients at substance abuse risk. Open Addict J. 2012; 4:58-64. PMC: 3526017. DOI: 10.2174/1874941001104010058. View

11.

Keyloun K, Hansen R, Hepp Z, Gillard P, Thase M, Devine E . Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD). CNS Drugs. 2017; 31(5):421-432. PMC: 5425490. DOI: 10.1007/s40263-017-0417-0. View